中国心血管病研究2024,Vol.22Issue(6) :481-509.DOI:10.3969/j.issn.1672-5301.2024.06.001

心房颤动合并脑卒中的抗凝策略及综合管理建议

Anticoagulation strategy and comprehensive management of patients with atrial fibrillation and stroke

《中国心血管病研究》杂志编辑委员会 姚焰 屈正 梅举 郭军 郑黎晖
中国心血管病研究2024,Vol.22Issue(6) :481-509.DOI:10.3969/j.issn.1672-5301.2024.06.001

心房颤动合并脑卒中的抗凝策略及综合管理建议

Anticoagulation strategy and comprehensive management of patients with atrial fibrillation and stroke

《中国心血管病研究》杂志编辑委员会 姚焰 屈正 梅举 郭军 郑黎晖
扫码查看

摘要

心房颤动合并脑卒中患者是再发脑卒中和出血的高危人群,其抗凝方案的制定是临床诊疗中的难点.本文根据国内外最新临床研究,参考相关指南,结合我国国情及临床实践,对抗凝适应证及方案进行了系统阐述,并根据现有证据做出推荐,以期促进和规范心房颤动合并脑卒中患者的抗凝策略和综合管理,指导临床应用.

Abstract

Patients with atrial fibrillation and stroke are at an increased risk of recurrent stroke and bleeding events.It is very challenging to make an anticoagulation strategy of this patients in clinical.Based on the latest trials and guidelines,and in the Chinese context and clinical practice,the present consensus comprehensively elaborates the anticoagulant strategy and makes recommendations based on the available evidence aiming to standardize and improve the anticoagulation treatment and comprehensive management of patients with atrial fibrillation and stroke.

关键词

心房颤动/脑卒中/抗凝治疗/CHA2DS2-VASc评分/HAS-BLED评分/NIHSS评分/口服抗凝药/华法林

Key words

Atrial fibrillation/Cerebral stroke/Anticoagulant treatment/CHA2DS2-VASc score/HAS-BLED score/NIHSS score/Oral anticoagulation/Warfarin

引用本文复制引用

出版年

2024
中国心血管病研究
中国医师协会,煤炭总医院

中国心血管病研究

CSTPCD
影响因子:0.878
ISSN:1672-5301
段落导航相关论文